Derma Sciences Inc. (DSCI) Swings to Q4 Profit

April 1, 2010 7:18 AM EDT
Derma Sciences Inc. (NASDAQ: DSCI) reports Q4 EPS of $0.01, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $13.65 million, compared to $12.56 million in Q408.

You May Also Be Interested In

Related Categories


Add Your Comment